“Among those aged between 25 and 49, as in 2020, a 5.1% HIV incidence was recorded while in 2024, 2.9% was reported,” the GDoH said. According to the department, the new HIV infection ...

Since the start of the HIV (human immunodeficiency virus) epidemic back in 1981, an estimated 75.7 million people have been diagnosed with HIV worldwide, and 32.7 million people have died of ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Disparities in HIV diagnosis rates were observed between Black and White individuals in the US from 2017 to 2021.

We have to care about men. We have to care about our ... and North Asia are all still seeing the expansion of HIV. If the President’s Emergency Plan for AIDS Relief (PEPFAR) and the United ...

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

New Study Identifies Key Protein's Role in Psoriasis Jan. 31, 2025 — In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

Medical experts note that these persistent changes, especially when combined with other symptoms, should prompt medical evaluation. Skin changes often provide early indicators of HIV infection ...

The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV infection and set a date of June 19 to decide on its approval, Gilead ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

Bush-era program for combatting HIV and AIDS around the globe. That program has now been largely dismantled by the Trump administration. A Gilead spokesperson declined to comment on what cuts to ...